Correlation Between Adhera Therapeutics and Emmaus Life
Can any of the company-specific risk be diversified away by investing in both Adhera Therapeutics and Emmaus Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adhera Therapeutics and Emmaus Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adhera Therapeutics and Emmaus Life Sciences, you can compare the effects of market volatilities on Adhera Therapeutics and Emmaus Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adhera Therapeutics with a short position of Emmaus Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adhera Therapeutics and Emmaus Life.
Diversification Opportunities for Adhera Therapeutics and Emmaus Life
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Adhera and Emmaus is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Adhera Therapeutics and Emmaus Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emmaus Life Sciences and Adhera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adhera Therapeutics are associated (or correlated) with Emmaus Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emmaus Life Sciences has no effect on the direction of Adhera Therapeutics i.e., Adhera Therapeutics and Emmaus Life go up and down completely randomly.
Pair Corralation between Adhera Therapeutics and Emmaus Life
If you would invest 26.00 in Emmaus Life Sciences on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Emmaus Life Sciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adhera Therapeutics vs. Emmaus Life Sciences
Performance |
| Timeline |
| Adhera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Emmaus Life Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adhera Therapeutics and Emmaus Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adhera Therapeutics and Emmaus Life
The main advantage of trading using opposite Adhera Therapeutics and Emmaus Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adhera Therapeutics position performs unexpectedly, Emmaus Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will offset losses from the drop in Emmaus Life's long position.| Adhera Therapeutics vs. Enveric Biosciences | Adhera Therapeutics vs. Akeso, Inc | Adhera Therapeutics vs. Avax Techs | Adhera Therapeutics vs. Ascletis Pharma |
| Emmaus Life vs. NRx Pharmaceuticals | Emmaus Life vs. Cell Source | Emmaus Life vs. Anebulo Pharmaceuticals | Emmaus Life vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |